共 237 条
- [1] Alvarez-Erviti L(2011)Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes Nat. Biotechnol. 29 341-345
- [2] Seow Y(2013)Extracellular vesicles: biology and emerging therapeutic opportunities Nat. Rev. Drug Discov. 12 347-357
- [3] Yin H(2012)Treatment of HER2-positive breast cancer: current status and future perspectives Nat. Rev. Clin. Oncol. 9 16-32
- [4] Betts C(2009)Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 Nat. Rev. Cancer. 9 463-475
- [5] Lakhal S(2007)miRNAs in cancer: approaches, aetiology, diagnostics and therapy Hum. Mol. Genet. 16 R106-R113
- [6] Wood MJ(2006)RNAi therapeutics: a potential new class of pharmaceutical drugs Nat. Chem. Biol. 2 711-719
- [7] Andaloussi EL(2004)Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines Int. J. Cancer. 108 71-77
- [8] Mager I(2013)Safety and efficacy of RNAi therapy for transthyretin amyloidosis N. Engl. J. Med. 369 819-829
- [9] Breakefield XO(2014)Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice Mov. Disord. 29 1476-1485
- [10] Wood MJ(2008)Drug delivery and nanoparticles: applications and hazards Int. J. Nanomed. 3 133-149